Cue Biopharma's average Accounts Receivable for the
three
months ended in Mar. 2024 was $1.55 Mil. Cue Biopharma's Revenue for the
three
months ended in Mar. 2024 was $1.72 Mil.
Hence, Cue Biopharma's Days Sales Outstanding for the
three
months ended in Mar. 2024 was 82.32.
The historical rank and industry rank for Cue Biopharma's Days Sales Outstanding or its related term are showing as below:
CUE'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.7 Med: 79.69 Max: 469.08
Current: 63.33
During the past 9 years, Cue Biopharma's highest Days Sales Outstanding was 469.08. The lowest was 55.70. And the median was 79.69.
CUE's Days Sales Outstanding is ranked better than 57% of 893
companies
in the Biotechnology industry
Industry Median: 72.43
vs CUE: 63.33
Cue Biopharma's Days Sales Outstanding
increased
from Mar. 2023 (61.73) to Mar. 2024 (82.32).
Cue Biopharma Days Sales Outstanding Historical Data
The historical data trend for Cue Biopharma's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cue Biopharma's Days Sales Outstanding
For the Biotechnology subindustry, Cue Biopharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cue Biopharma's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cue Biopharma's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Cue Biopharma's Days Sales Outstanding falls into.
Cue Biopharma Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cue Biopharma (NAS:CUE) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Cue Biopharma Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Cue Biopharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Cue Biopharma (Cue Biopharma) Business Description
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CUE has been successfully added to your 